Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 3,648 shares of the stock in a transaction dated Friday, October 2nd. The shares were sold at an average price of $24.64, for a total transaction of $89,886.72. Following the completion of the transaction, the vice president directly owned 67,085 shares of the company’s stock, valued at approximately $1,652,974.40. This trade represents a 5.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Arteris Price Performance
Shares of NASDAQ:AIP traded down $0.69 during midday trading on Monday, hitting $23.97. 784,618 shares of the stock were exchanged, compared to its average volume of 730,172. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.03. The company has a 50 day moving average price of $24.86 and a 200-day moving average price of $28.55. Arteris, Inc. has a twelve month low of $12.06 and a twelve month high of $50.26. The stock has a market cap of $1.18 billion, a P/E ratio of -27.55 and a beta of 1.90.
Arteris (NASDAQ:AIP – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%.The firm had revenue of $24.13 million for the quarter, compared to analysts’ expectations of $23.48 million. On average, research analysts forecast that Arteris, Inc. will post -0.68 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several brokerages recently commented on AIP. Craig Hallum assumed coverage on Arteris in a report on Monday, September 21st. They set a “buy” rating and a $30.00 target price on the stock. Roth Capital assumed coverage on shares of Arteris in a report on Tuesday, August 4th. They issued a “buy” rating and a $40.00 price target for the company. Oppenheimer started coverage on shares of Arteris in a report on Thursday, July 16th. They issued an “outperform” rating and a $40.00 price objective on the stock. Jefferies Financial Group raised Arteris from a “hold” rating to a “buy” rating and increased their price target for the stock from $35.00 to $50.00 in a research note on Friday, August 7th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $38.00 price target on shares of Arteris in a research report on Friday, August 7th. Six analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Arteris has an average rating of “Moderate Buy” and an average target price of $39.43.
Check Out Our Latest Stock Report on AIP
About Arteris
Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.
The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.
Read More
- Five stocks we like better than Arteris
- NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
